期刊文献+

全膝关节置换术围术期血液管理的研究进展 被引量:11

Research advances on perioperative blood management for total knee arthroplasty
原文传递
导出
摘要 全膝关节置换术后常并发急性失血性贫血。异体输血是目前纠正术后贫血的主要措施,虽然可以快速纠正贫血,但可能引起各种严重的并发症及其他问题,包括感染、肢体康复时间延长、住院时间延长、死亡率增加等。全膝关节置换术围术期采取血液管理措施可有效降低术后失血,减少或避免异体输血。围术期血液管理措施主要分为三部分:术前纠正贫血、自体血储存;术中止血带、抗纤溶药、局部止血剂、急性等容性血液稀释等的应用;术后自体血回输、遵循输血指征、处理引流和体位控制等。围术期血液管理旨在减少术后失血、降低输血率、改善预后、促进术后康复及降低医疗成本。血液管理理念必须贯穿整个围手术期,临床医生需要根据患者实际情况,结合不同血液管理方法的特点,权衡利弊,制定出高效合理的个体化治疗方案。 Acute blood loss anemia is the most common surgical complication of total knee arthroplasty. Currently, allogeneic transfusion has been the major method of managing postoperative anemia. Although allogeneic transfusion can correct anaemic condition temporarily, it can lead to severe complications, such as postoperative infection, prolongation of physical recovery, increased length of hospital stay, and increased mortality. Perioperative blood management can effectively reduce blood loss and transfusion rate. These strategies mainly focus on three parts: therapy for anemia and autologous blood donation before operation; application of a tourniquet, antifibrinolytic drugs, topical hemostatic agents and acute normovolemic hemodilution during operation; selection of reinfusion systems, restrictive transfusion thresholds, drainage and knee position after operation. Perioperative blood management should run throughout the perioperative period, which mainly aims at reducing blood loss and blood transfu- sion, improving prognosis, promoting the postoperative recovery and lowering the medical cost. Depending on the actual situations of patients, surgeons should combine different major characteristics of each strategy and weigh the pros and cons to make effective and reasonable individualized treatment plan.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2016年第3期187-192,共6页 Chinese Journal of Orthopaedics
  • 相关文献

参考文献69

  • 1Kalairajah Y, Simpson D, Cossey AJ, et al. Blood loss after total knee replacement: effects of computer-assisted surgery[J]. J Bone Joint Surg Br, 2005, 87(11): 1480-1482. DOI: 10.1302/0301- 620X.87B11.16474.
  • 2Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature[J]. Anesthesiol- ogy, 2010, 113(2): 482-495. DOI: 10.1097/ALN.ObO13e3181e08 e97.
  • 3Klein HG. How safe is blood, really?[J]. Biologicals, 2010, 38(1): 100-104. DOI: lO.1016/j.biologicals.2009.10.008.
  • 4Lee QJ, Mak WP, Yeung ST, et al. Blood management protocol for total knee arthroplasty to reduce blood wastage and unnecessary transfusion[J]. J Orthop Surg (Hong Kong), 2015, 23(1): 66-70.
  • 5Holt JB, Miller B J, Callaghan JJ, et al. Minimizing blood transfu- sion in total hip and knee arthroplasty through a multimodal ap- proach[J]. J Arthroplasty, 2015. DOI: 10.1016/j.arth.2015.08. 025.
  • 6Epub ahead of print. Yang Y, Lv YM, Ding P J, et al. The reduction in blood loss with intra- articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized con- trolled trial[J]. Eur J Orthop Surg Traumatol, 2015, 25(1): 135- 139. DOI: 10.1007/s00590-014-1461-9.
  • 7Yang Y, Li H, Li B, et al. Efficacy and safety of iron supplementa- tion for the elderly patients undergoing hip or knee surgery: a meta- analysis of randomized controlled trials[J]. J Surg Res, 2011, 171 (2): e201-207. DOI: 10.1016/j.jss.2011.08.025.
  • 8Baron DM, Hochrieser H, Posch M, et al. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery pa- tients[J]. Br J Anaesth, 2014, 113(3): 416-423. DOI: 10.1093/bja/ aeu098.
  • 9Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a sys- tematic review[J]. Transfus Med Rev, 2013, 27(4): 221-234. DOI: 10.1016/j.tmrv.2013.09.001.
  • 10Cuenca J, Garcia-Erce JA, Martinez F, et al. Preoperative haema- tinics and transfusion protocol reduce the need for transfusion af- ter total knee replacement[J]. Int J Surg, 2007, 5(2): 89-94. DOI: 10.1016/j.ijsu.2006.02.003.

二级参考文献18

  • 1预防骨科大手术深静脉血栓形成指南(草案)[J].中华骨科杂志,2007,27(10):790-792. 被引量:111
  • 2Gardner M J, Demetrakopoulos D, Klepchick PR, et al. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty [ J ]. Int Orthop ,2007,31 ( 3 ) :309-313.
  • 3Aggarwal AK , Shashikanth VS, Marwaha N. Platelet-rich plasma prevents blood loss and pain and enhances early functional outcome after total knee arthroplasty: a prospective randomised controlled study[J]. Int Orthop,2014,38(2) :387-395.
  • 4Senavongse W, Farahmand F, Jones J, et al. Quantitative measurement of patellofemoral joint stability: force-displacement behavior of the human patella in vitro [ J]. J Orthop Res,2003,21 (5) :780-786.
  • 5de Almeida AM, Demange MK, Sobrado MF, et al. Patellar tendon healing with platelet-rich plasma: a prospective randomized controlled trial[ J]. Am J Sports Med, 2012,40(6) :1282-1288.
  • 6Taylor DW, Petrera M, Hendry M, et al. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries[ J]. Clin J Sport Med, 2011 ,21 (4) :344-352.
  • 7Sanchez-Gonzdlez DJ, Mandez-Bolaina E, Trejo-Bahena NI. Platelet-rieh plasma peptides: key for regeneration [ J/OL]. Int J Pept,2012 [2014-06-05 ]. http://www, hindawi, corn/journals/ ijpep/2012/532519/doi : 10.1155/2012/532519.
  • 8Sampson S, Gerhardt M, Mandelbanm B. Platelet rich plasma injection grafts for musculaskeletal injuries: a review [ J ]. Curr Rev Museuloskelet Med,2008,1 (3-4) : 165-174.
  • 9Freymiller EG. Platelet-rieh plasma: evidence to support its use [ J ]. J Oral Maxillofac Surg,2004,62 ( 8 ) : 1046.
  • 10Kaux JF, Crielaard JM. Platelet-rich plasma application in the management of chronic tendinopathies [ J ]. Acta Orthop Belg, 2013,79(1) :10-15.

共引文献6

同被引文献102

引证文献11

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部